Move provides emerging leader in innovation with opportunity to scale and access R&D, Bioscience & Healthcare ecosystem talent LOWELL, Mass., June 30, 2021 – Anuncia Inc., a therapeutic medical device […]
Earlier this year, Anuncia Inc., a medical device company focused on the development of treatment devices for hydrocephalus and other cerebrospinal fluid (CSF) disorders, announced that the ReFlow™ System Mini […]
These are the companies in the private sector that medtech analysts have called attention to in 2021. Updated May 12, 2021 to reflect 10 new additions, based on recent analyst reports. […]
Anuncia’s breakthrough technology has received an honorable mention in the Health category of this year’s World Changing Ideas Awards LOWELL, Mass., May 4, 2021 – Anuncia Inc., an emerging leader in cerebrospinal […]
LOWELL, Mass., March 2, 2021 /PRNewswire/ — Anuncia Inc., an emerging leader in Cerebral Spinal Fluid (CSF) management, received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for its ReFlow™ System Mini […]
Alcyone Lifesciences is a medical technology company based out of Lowell, MA, which specializes in central nervous system (CNS) drug delivery platforms for targeted infusions of the brain or spinal cord. […]
LOWELL, Mass., May 22, 2018 /PRNewswire/ — Anuncia, Inc., a privately-held company focused on better treatment of hydrocephalus and cerebrospinal fluid dysfunctions, announced, today, the successful first-in-human implantation of its Alivio ReFlow™ […]
A Boston neurosurgeon recently avoided doing emergency brain surgery on a young patient just by pressing on a new device. The Alivio ReFlow ventricular system was embedded beneath the scalp […]
Alcyone Lifesciences, Inc., announces the separation and spin-off of its Hydrocephalus business. The new company, known as Anuncia, Inc., is an independent company focused on innovative treatment of Hydrocephalus and […]
Additional information about the ReFlow™ System Mini is available by contacting Anuncia.
Disclaimer
The ReFlow™ System Mini and ReFlow Mini Flusher are FDA cleared for use in the treatment of patients with hydrocephalus or conditions where draining or shunting of cerebrospinal fluid (CSF) is medically indicated. The ReFlow™ System Mini and ReFlow™ Mini Flusher are not for everyone; please consult your doctor. The ReFlow™ System Mini and ReFlow™ Mini Flusher are only available in the United States. The ReFlow™ System Mini and ReFlow™ Mini Flusher are prescription devices sold by or on the order of a physician.
Caution: FDA (USA) law restricts this device to sale by or on the order of a physician. Refer to product package insert for instructions, warnings, precautions and complications.
Medical Advice Disclaimer
Information on this site is for informational purposes only and should not be used as a substitute for talking with your doctor. No representation is made that the information provided is current, complete, or accurate. Always consult with your doctor about your medical questions, health, diagnosis, and treatment information.
Trademark Legal Notice
All logos, and brands are property of their respective owners in the United States and/or other countries. All company, product and service names used on this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement.
Anuncia Inc. is not affiliated with or an official partner of MD&DI, Fast Company, and The FDA.